Daniel Arias
Stock Analyst at Stifel
(5.00)
# 7
Out of 5,131 analysts
164
Total ratings
62.11%
Success rate
144.3%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $583 → $700 | $618.86 | +13.11% | 17 | Jan 9, 2026 | |
| GH Guardant Health | Maintains: Buy | $100 → $120 | $110.17 | +8.92% | 5 | Jan 9, 2026 | |
| BLLN BillionToOne | Initiates: Buy | $145 | $85.94 | +68.72% | 1 | Dec 1, 2025 | |
| EXAS Exact Sciences | Downgrades: Hold | $80 → $105 | $102.11 | +2.83% | 8 | Nov 28, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,485.12 | +7.74% | 8 | Nov 10, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $54.46 | -26.55% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $12.41 | -3.30% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $104.43 | +5.33% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $65.70 | -8.68% | 11 | May 8, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $238.37 | +9.07% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.43 | +529.37% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $20.46 | -12.02% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $5.40 | +11.11% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $66.27 | -1.92% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $396.75 | -9.26% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $148.52 | +1.67% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $54 → $44 | $48.29 | -8.59% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.93 | +154.45% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $166.82 | +24.09% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $141.07 | +41.77% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.64 | +204.88% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.34 | +199.85% | 2 | May 31, 2022 |
Thermo Fisher Scientific
Jan 9, 2026
Maintains: Buy
Price Target: $583 → $700
Current: $618.86
Upside: +13.11%
Guardant Health
Jan 9, 2026
Maintains: Buy
Price Target: $100 → $120
Current: $110.17
Upside: +8.92%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $85.94
Upside: +68.72%
Exact Sciences
Nov 28, 2025
Downgrades: Hold
Price Target: $80 → $105
Current: $102.11
Upside: +2.83%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,485.12
Upside: +7.74%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $54.46
Upside: -26.55%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $12.41
Upside: -3.30%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $104.43
Upside: +5.33%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $65.70
Upside: -8.68%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $238.37
Upside: +9.07%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.43
Upside: +529.37%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $20.46
Upside: -12.02%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $5.40
Upside: +11.11%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $66.27
Upside: -1.92%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $396.75
Upside: -9.26%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $148.52
Upside: +1.67%
May 1, 2024
Maintains: Hold
Price Target: $54 → $44
Current: $48.29
Upside: -8.59%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.93
Upside: +154.45%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $166.82
Upside: +24.09%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $141.07
Upside: +41.77%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.64
Upside: +204.88%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.34
Upside: +199.85%